RxDoctor Payments Data

Maria Norona Norona

Family · Hialeah, FLNPI 1811474497

Payments from drug & device makers

$841in general payments, 2019–2025

Across 42 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$234
  • Amgen$222
  • GSK$183
  • Incyte Corporation$88
  • Lilly USA, LLC$46
  • Novo Nordisk$43
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$841100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$841 in reported general payments places this provider in the 65th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$18,323
Medicare patients
28
Services billed
211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol175$157,302
OzempicSemaglutide144$135,223
Repatha SureclickEvolocumab195$110,055
Breztri AerosphereBudesonide/Glycopyr/Formoterol95$60,948
MounjaroTirzepatide44$44,863
Trelegy ElliptaFluticasone/Umeclidin/Vilanter64$40,935
LinzessLinaclotide61$35,121
SynjardyEmpagliflozin/Metformin Hcl38$31,742
RexultiBrexpiprazole20$28,954
EliquisApixaban40$24,575
EntrestoSacubitril/Valsartan32$21,414
TradjentaLinagliptin27$20,384
VascepaIcosapent Ethyl52$19,386
JanuviaSitagliptin Phosphate27$17,902
TrulicityDulaglutide14$13,463

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Airsupra$234$223,388281 claims
Novo NordiskOzempic$43$135,223144 claims
Lilly USA, LLCMounjaro, Trulicity$46$58,32658 claims
GSKTrelegy Ellipta$183$40,93564 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 14,618 family providers in Florida.

Other family in Hialeah

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →